Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Albiges

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Bulletin Du Cancer|April 10, 2009
[Prognosis and predictive factors in prostate cancer]L Albiges-Sauvin, A Lévy, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Novel and bone-targeted agents for CRPCK Fizazi, L Albiges, C Massard, et al.
Bulletin Du Cancer|December 19, 2008
[Everolimus (RAD001) and solid tumours: a 2008 summary]A Lévy, L Albiges Sauvin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 14, 2025
Neoadjuvant Stereotactic Ablative Body Radiotherapy for Renal Cell Carcinoma With Thrombus: Do or Do Not?J Le Guévelou, K Bensalah, L Albiges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2011
Evaluating the risk-benefit ratio of adjuvant trastuzumab-based therapy for T1a,bN0M0 HER2-positive breast carcinomasM J Rodrigues, L Albiges-Sauvin, J Wassermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2015
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaH Izzedine, L Derosa, G Le Teuff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
How to select targeted therapy in renal cell cancerB Escudier, L Albiges, A Blesius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2005
Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastasesL Albiges, F André, C Balleyguier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinomaL Albiges, P Barthélémy, M Gross-Goupil, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|April 10, 2009
[Prognosis and predictive factors in prostate cancer]L Albiges-Sauvin, A Lévy, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Novel and bone-targeted agents for CRPCK Fizazi, L Albiges, C Massard, et al.
Bulletin Du Cancer|December 19, 2008
[Everolimus (RAD001) and solid tumours: a 2008 summary]A Lévy, L Albiges Sauvin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 14, 2025
Neoadjuvant Stereotactic Ablative Body Radiotherapy for Renal Cell Carcinoma With Thrombus: Do or Do Not?J Le Guévelou, K Bensalah, L Albiges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2011
Evaluating the risk-benefit ratio of adjuvant trastuzumab-based therapy for T1a,bN0M0 HER2-positive breast carcinomasM J Rodrigues, L Albiges-Sauvin, J Wassermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2015
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaH Izzedine, L Derosa, G Le Teuff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
How to select targeted therapy in renal cell cancerB Escudier, L Albiges, A Blesius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2005
Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastasesL Albiges, F André, C Balleyguier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinomaL Albiges, P Barthélémy, M Gross-Goupil, et al.
Pageof 7